Evofem Biosciences

Entity > Corporation > US > New York City New York > Evofem Biosciences

About Evofem Biosciences

Evofem Biosciences, Inc. is a biopharmaceutical company that provides women with reproductive and contraceptive care products. Evofem Biosciences, Inc.'s first commercial product, Phexxi, is the first and only hormone-free prescription vaginal gel approved in the United States to prevent pregnancy.

Evofem Biosciences, Inc. Manufactures the First Hormone-Free Product for Women: Evofem Biosciences, Inc. is revolutionising sexual and reproductive healthcare for women with a first-of-its-kind innovative hormone-free contraceptive. Phexxi provides a hormone-free contraceptive option for women who cannot or do not want to use a hormonal contraceptive. Phexxi is the hormone-free birth control method women have been waiting for. Phexxi is 93% pregnancy prevention when used as prescribed by a doctor.

Evofem Biosciences, Inc.'s Founding And Headquarters: Evofem Biosciences, Inc. was founded on January 1, 2009 by Jay File and Saundra Pelletier. Evofem Biosciences, Inc. is currently headquartered in San Diego, California, USA.

Industry: Health > Reproductive Health

More information about Evofem Biosciences

Company Attribute Value
Address StreetAddress: 12400 High Bluff Dr Ste 600, AddressLocality: San Diego, AddressRegion: California, PostalCode: 92130, AddressCountry: United States
Founding Date 2007
Name Evofem Biosciences
Number Of Employees 119
Revenue $15,567,000 USD
Ticker Symbol NASDAQ: EVFM
Url evofem
Facebook facebook
Linkedin linkedin
Twitter twitter
Google google

Evofem Biosciences

us

New York City, US
18 Sep 2023

New York City, US
18 Sep 2023

Evofem Biosciences

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://www.evofem.com/
Evofem Biosciences, Inc. (EVFM) - Company Information and ...
Evofem Biosciences is revolutionizing women's sexual and reproductive healthcare with a first-in-class innovative hormone-free contraceptive. · Significant
https://www.linkedin.com › company › evofem
Evofem Biosciences
Evofem Biosciences | 8692 followers on LinkedIn. Developing and commercializing products that address unmet needs in women's sexual and reproductive health.
https://twitter.com/Evofem?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Evofem Biosciences (@Evofem) · Twitter
https://www.prnewswire.com › news-releases › evofe...
Evofem Biosciences Announces Financial Results for the ...
Aug 14, 2023 — 14, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) today announced financial results for the second quarter and first half of 2023.
https://finance.yahoo.com › quote › EVFM
Evofem Biosciences, Inc. (EVFM) Stock Price, News, Quote ...
Find the latest Evofem Biosciences, Inc. (EVFM) stock quote, history, news and other vital information to help you with your stock trading and investing.
https://www.sec.gov › a20230320_evfmxdownsizing
Press Release, dated March 21, 2023
SAN DIEGO, March 21, 2023 – Evofem Biosciences, Inc., (OTCQB: EVFM) (the “Company”) today announced it has implemented measures to lower its operating ...
https://www.sec.gov › Archives › edgar › data
Document
About Evofem Biosciences, Inc. Evofem Biosciences, Inc. (Nasdaq: EVFM) is developing and commercializing innovative products to address unmet needs in women's ...
https://www.prnewswire.com › news-releases › evofe...
Evofem Biosciences Announces Strong Preliminary ...
Jun 1, 2023 — Evofem Biosciences, Inc., is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health ...
Related Searches
Related Searches
evofem biosciences news
evofem biosciences stocktwits
evofem biosciences delisting
Knowledge Panel
Knowledge Panel

Evofem Biosciences Inc (Commercial company)

evofem.com/

Evofem Biosciences, Inc., is focused on commercializing innovative products to address unmet needs in women's sexual and reproductive health. The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel.

prnewswire.com/news-releases/evofem-biosciences-announces-financial-results-for-the-second-quarter-of-2023-301900203.html#:~:text=Evofem%20Biosciences%2C%20Inc.%2C%20is,demand%20prescription%20contraceptive%20vaginal%20gel.
  • Stock price : EVFM (OTCMKTS) $0.17 +0.02 (+13.33%)Sep 15, 4:00 PM EDT - Disclaimer
  • CEO : Saundra Pelletier (Feb 2015–)
  • Headquarters : California
  • Founded : 2007
  • Subsidiaries : Evofem Inc., Evofem North America, Inc

Related Entities Evofem Biosciences

Entity Home Kalicube Pro Entity Page
Evofem Biosciences Entity Home Evofem Biosciences on Kalicube

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 194144